Remove 2018 Remove Kidney Disease Remove Myocardial Infarction
article thumbnail

Abstract 4148106: Hemophilia and Cardiovascular disease in the United States: Prevalence, Risk factors, and outcomes.

Circulation

The secondary outcomes comprise the odds of adverse events, including myocardial infarction, ischemic stroke, transient ischemic attack (TIA), occlusive atherosclerotic disease, percutaneous coronary intervention, and coronary artery bypass graft (CABG)., The hemophilia cohort was slightly older (63.2[16.8]

article thumbnail

Development and validation of prediction models for incident atrial fibrillation in heart failure

Open Heart

Methods Using the Danish Heart Failure Registry, we conducted a nationwide registry-based cohort study of all incident HF patients diagnosed from 2008 to 2018 and without history of AF. The objective was to develop clinical prediction models for 1-year risk of AF. Administrative data sources provided the predictors.

article thumbnail

Predicting survival in patients with severe heart failure: Risk score validation in the HELP‐HF cohort

European Journal of Heart Failure

Recursive feature elimination was employed to identify the most relevant features in predicting the risk of mortality. Abstract Aims Accurate selection of patients with severe heart failure (HF) who might benefit from advanced therapies is crucial.

article thumbnail

Incident cardiovascular, renal, metabolic diseases and death in individuals identified for risk-guided atrial fibrillation screening: a nationwide cohort study

Open Heart

We compared events rates for new diagnoses of cardio-renal-metabolic diseases and death in individuals identified at higher versus lower-predicted AF risk. Methods From the UK Clinical Practice Research Datalink-GOLD dataset, 2 January 1998–30 November 2018, we identified individuals aged ≥30 years without known AF.

article thumbnail

Expert Perspective: The Obesity Paradox with Salvatore Carbone, PhD

Cardiometabolic Health Congress

Dr. Carbone: The new physical activity guidelines were published in 2018, an update after 10 years from the prior guidelines. [11] 17] Glycemic improvement alone, however, has not been associated with improved risk of macrovascular diabetes complications, such as myocardial infarction, stroke and heart failure. Lavie, Carl J.,

Obesity 52
article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

article thumbnail

The nonlinear relationship between estimated glomerular filtration rate and cardiovascular disease in US adults: a cross-sectional study from NHANES 2007–2018

Frontiers in Cardiovascular Medicine

This study examines the association between eGFR and cardiovascular disease (CVD) risk in a representative cohort of the US adult population.MethodsA cross-sectional analysis was conducted using data from the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2018.